BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 12832738)

  • 1. The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.
    Basile C; De Padova F; Montanaro A; Giordano R
    J Nephrol; 2003; 16(3):384-6. PubMed ID: 12832738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sterile peritonitis after administration of icodextrin].
    Ekart R; Pecovnik-Balon B; Dvorsak B; Hojs R
    Acta Med Croatica; 2002; 56(4-5):185-7. PubMed ID: 12768899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis.
    Boer WH; Vos PF; Fieren MW
    Perit Dial Int; 2003; 23(1):33-8. PubMed ID: 12691504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.
    Touré F; Lavaud S; Mohajer M; Lavaud F; Canivet E; Nguyen P; Chanard J; Rieu P
    Kidney Int; 2004 Feb; 65(2):654-60. PubMed ID: 14717938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Icodextrine peritoneal dialysis solution in clinical practice].
    Opatrná S
    Vnitr Lek; 2008 Dec; 54(12):1155-60. PubMed ID: 19140524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids.
    Glorieux G; Lameire N; Van Biesen W; Dequidt C; Vanholder R
    Nephrol Dial Transplant; 2003 Aug; 18(8):1648-53. PubMed ID: 12897108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
    Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterile icodextrin-associated peritonitis may induce hypersensitivity and recurrent peritonitis on re-challenge.
    Enia G; Mandalari A; Ventura G; Pustorino D; Panuccio V
    Nephrol Dial Transplant; 2003 Mar; 18(3):626. PubMed ID: 12584300
    [No Abstract]   [Full Text] [Related]  

  • 12. Icodextrin and intraperitoneal inflammation.
    Moriishi M; Kawanishi H
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.
    Posthuma N; ter Wee P; Donker AJ; Dekker HA; Oe PL; Verbrugh HA
    Perit Dial Int; 1999; 19(4):334-42. PubMed ID: 10507814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
    Parikova A; Zweers MM; Struijk DG; Krediet RT
    Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
    Rippe B; Levin L
    Kidney Int; 2000 Jun; 57(6):2546-56. PubMed ID: 10844624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
    Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
    Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions.
    Hwang JC; Wang HY; Wang CT; Chen HC
    J Nephrol; 2006; 19(6):758-63. PubMed ID: 17173249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icodextrin-associated peritonitis: what conclusions thus far?
    Goffin E; Cosyns JP; Pirson F; Devuyst O
    Nephrol Dial Transplant; 2003 Dec; 18(12):2482-5. PubMed ID: 14605268
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient sterile chemical peritonitis with icodextrin: clinical presentation, prevalence, and literature review.
    Tintillier M; Pochet JM; Christophe JL; Scheiff JM; Goffin E
    Perit Dial Int; 2002; 22(4):534-7. PubMed ID: 12322832
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of sterile peritonitis associated with icodextrin solution.
    Reichel W; Schulze B; Dietze J; Mende W
    Perit Dial Int; 2001; 21(4):414-5. PubMed ID: 11587408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.